Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income	$ 16,595,920	$ 12,600,294
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	136,991	(142,519)
Other-than-temporary impairments	650,956	300,000
Realized investment gains, net	(13,678,981)	(12,340,077)
Change in fair value of equity securities	(12,530,315)	(10,416,758)
Realized trading (gains) losses included in income	132,518	0
Amortization of cost of insurance acquired	775,906	806,065
Depreciation	1,039,453	1,067,297
Stock-based compensation	353,887	360,812
Charges for mortality and administration of universal life and annuity products	(5,211,485)	(6,602,846)
Interest credited to account balances	4,088,309	4,221,969
Change in accrued investment income	440,099	870,839
Change in reinsurance receivables	374,515	198,575
Change in policy liabilities and accruals	(4,331,160)	(2,237,947)
Change in income taxes receivable (payable)	592,995	270,518
Change in other assets and liabilities, net	1,988,577	5,985,699
Net cash used in operating activities	(8,581,815)	(5,058,079)
Proceeds from investments sold and matured:
Fixed maturities available for sale	14,390,181	66,408,611
Equity securities	14,385,393	2,169,989
Mortgage loans	5,283,749	8,878,073
Real estate	13,283,895	14,341,204
Notes receivable	20,261,459	6,783,702
Policy loans	1,635,686	1,599,896
Short-term investments	0	7,549,076
Total proceeds from investments sold and matured	69,240,363	107,730,551
Cost of investments acquired:
Fixed maturities available for sale	(14,634,233)	(56,940,883)
Equity securities	(2,092,304)	(12,687,839)
Trading securities	(132,518)	0
Mortgage loans	(4,367,644)	(91,954)
Real estate	(1,958,982)	(15,704,151)
Notes receivable	(16,031,605)	(11,496,998)
Policy loans	(1,235,340)	(1,244,976)
Short-term investments	(10,403,628)	(7,549,076)
Total cost of investments acquired	(50,856,254)	(105,715,877)
Net cash provided by investing activities	18,384,109	2,014,674
Cash flows from financing activities:
Policyholder contract deposits	4,669,825	4,696,980
Policyholder contract withdrawals	(4,389,622)	(5,234,212)
Purchase of treasury stock	(909,368)	(1,329,148)
Non controlling contributions/(distributions) of consolidated subsidiary	(535,662)	(374,252)
Net cash used in financing activities	(1,164,827)	(2,240,632)
Net increase (decrease) in cash and cash equivalents	8,637,467	(5,284,037)
Cash and cash equivalents at beginning of year	20,150,162	25,434,199
Cash and cash equivalents at end of year	$ 28,787,629	$ 20,150,162